Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(66.7%)
Phase 2
2(33.3%)
6Total
N/A(4)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04415086Phase 2Completed

Treatment of Patients With COVID-19 With Convalescent Plasma

Role: collaborator

NCT04176445Not ApplicableTerminated

Body Positioning and Pulmonary Aeration During Mechanical Ventilation

Role: collaborator

NCT04163497Not ApplicableUnknown

ICU Diaries and Its Effects After the Unit Discharge

Role: lead

NCT02611414Phase 2Unknown

Effectiveness of tDCS for the Treatment of Functional Dyspepsia

Role: lead

NCT01794325Not ApplicableCompleted

Transradial and Transfemoral Coronary Angiography by EXPERienced operaTors

Role: collaborator

NCT01724034Not ApplicableUnknown

Lung Ultrasound Assisting Weaning in Difficult-to-wean Patients

Role: lead

All 6 trials loaded